Vaccine makers’ shares jump after bird flu death in US
美国出现禽流感死亡病例，疫苗制造商股价上涨
Moderna, Pfizer, CureVac and Novavax register gains as health agency stresses risk to public ‘remains low’
Moderna、辉瑞、CureVac和Novavax股价上涨，卫生机构强调对公众的风险“仍然很低” 。
Shares in vaccine developers jumped on Tuesday after the US reported its first human death from the H5 strain of bird flu.
周二，在美国报告了首例H5株禽流感死亡病例后，疫苗开发商的股票大涨。
您已阅读5%（156字），剩余95%（3286字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。